Daily Schedule for Destin, FL CME Conference

Whether you practice full-time and strive to sharpen your skills, or you work occasionally and need to improve your knowledge base, there’s something for everyone here! Perhaps you just want to stay current and pass your recertification exams. Plus, this exciting program allows participants to come early and/or stay over the weekend for a vacation. Discounted hotel rates apply! Schedule is preliminary.

Topics, times and presenters subject to change.

APRN Pharm Credit to be updated

Product Theater (Non-CME) denoted by *
*Number of hours depends on your course selection. Rx denotes Pharmacology hours. Daily CME credits listed are the maximum number of credits available for that specific day.

Monday, June 6 – Early Registration 2:00 – 5:00 pm

Day One – Tuesday, June 7

Dermatology

Speaker

Cynthia Griffith, MPAS, PA-C

View Cynthia’s Bio

6:30 – 8:00 am

Registration and Breakfast

7:30 – 8:30 am

Psoriasis: Presentation, Exacerbators and Treatment (Rx 0.25)

Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being recognized as a systemic inflammatory disorder. According to current studies, more than 8 million Americans have psoriasis. A rapidly expanding body of literature supports additional associations between psoriasis and cardiometabolic diseases, gastrointestinal diseases, kidney disease, malignancy, infection, and mood disorders. Given the variety of manifestations of this condition, education of healthcare providers is essential to ensuring comprehensive medical care for patients with psoriasis. This session will provide an update on the diagnosis and treatment of psoriasis.

8:30 – 9:30 am

Benign Skin Lesions Uncoded

Can you recognize benign skin lesions from cancerous ones? So much of skin lesion identification and diagnosis is pattern recognition. This is a photo-filled talk that will expand your clinical diagnostic skills and ability to visually diagnose seborrheic keratoses, dermatofibromas, cherry angiomas, venous lakes so that you can distinguish them from skin cancer.

9:30 – 9:45 am

Break

9:45 – 11:15 am

Dermatologic Drugs and Drug Reactions (Rx 0.75)

What is the difference between a cream and a lotion? In the first half of this two-part talk, we will review common dermatologic drugs, vehicles and their uses. In the second half of the talk, we will discuss drug reactions ranging from the serious Toxic Epidermal Necrosis and Steven Johnson Syndrome to the benign. This lecture will demystify common medication culprits that cause drug reactions as well as initial labs to elucidate severe from self-limited drug rashes.

11:15 am – 12:30 pm

Sponsored Lunch or Lunch on Your Own

12:30 – 2:00 pm

Skin Cancer Explained (Rx 0.25)

The majority of skin lesions are benign, but when do you need to worry or biopsy? Skin cancer is by far the most common type of cancer. Basal cell carcinoma, squamous cell carcinoma, and melanoma could be cancers that you either diagnose or miss on a daily basis. This lecture will equip you to look at a spot and recognize concerning clinical features, be equipped to take the next step and biopsy the site, and have the knowledge to direct treatment of the cancer with medical or surgical treatments.

2:00 – 2:15 pm

Break

2:15 – 3:45 pm

Common Culprits in Pediatric and Adult Dermatology (Rx 0.5)

Every clinician that sees children and adults could benefit from this refresher on everything that is common in skin disease. In this case-based discussion, we will cover diagnosis and treatment tips for acne, warts, fungal infections, atopic dermatitis, and more. This will be a fast-paced and high-yield discussion packed with clinical pearls that you can use every day in your clinical practice.

Day Two – Wednesday, June 8

Cardiology & Emergency Medicine

Speaker

Leslie Davis, PhD, RN, ANP-BC, FAANP, FACC, FAHA, FPCNA

View Leslie’s Bio

6:30 – 8:00 am

Registration and Breakfast

7:30 – 8:30 am

Spot that Rhythm: 12 Lead ECG Interpretation (Part 1)

In this session, you will learn how the frontal, augmented, and chest (V) leads of the ECG align with the images on the printed copy of the 12 lead ECG. You will learn which two leads are the most useful to determine rate and rhythm. By the end of the first session, you will be a pro at on-the-spot interpretation of the underlying heart rate and rhythm.

8:30 – 9:30 am

Turned to the Side, Slower, Wider, What’s Wrong: 12 Lead ECG Interpretation (Part 2)

In this session, you will learn what is meant by axis, including likely causes and significance of an axis deviation, if present. You will use the “eyeball test” as one of the three ways to determine if left ventricular hypertrophy is present on a 12 lead ECG. You will get hands-on practice using a systematic approach to determine the difference between a right versus left bundle branch blocks in ECGs with wide QRS waves.

9:30 – 9:45 am

Break

9:45 – 11:15 am

Spot that Heart Attack: 12 Lead ECG Case Studies

This session will utilize a systematic approach for recognizing acute ischemia, acute injury, and infarction in case studies of 12 lead ECGs. You will get hands-on practice in interpreting case studies to apply the knowledge gained. After this session, you will be able to recognize acute ischemia like a pro.

11:15 am – 12:30 pm

Sponsored Lunch or Lunch on Your Own

12:30 – 2:00 pm

Stop the Stroke, Prevent the Bleed in Patients with Atrial Fibrillation

In this session, you will utilize evidence-based risk stratification scoring tools to determine whether your patient with atrial fibrillation needs chronic anticoagulation to prevent stroke while considering the likelihood of bleeding. We will compare newer versus traditional anticoagulation options to stroke prevention, even for those with chronic kidney disease. The discussion will conclude with reviewing a systematic approach to managing bleeding, including the use of newly approved reversal agents, as appropriate, in patients on chronic anticoagulation.

2:00 – 2:15 pm

Break

2:15 – 3:45 pm

Ref and Pef: The Not So Identical Twins of Heart Failure

The treatment of patients with heart failure (HF) has become very complex, including figuring out how to optimize guideline-directed medical therapy for patients with HF with reduced ejection fraction and HF with preserved ejection fraction. In this session, we will cover the latest treatment guidelines for treating adults with both types of HF. We will review how to start and titrate optimal medical therapy, including traditional baseline therapy and two new classes of medications. You will learn strategies for how to overcome barriers to medication titration from an expert in the field, including which circumstances would trigger a referral to a HF specialist. Templates for conducting phone visits (within 72 hours) and clinic visits (within 7-10 days) for those hospitalized for HF will be shared for immediate use in your clinical practice. Patient education resources and a user-friendly app for health care providers will also be shared.

Day Three – Thursday, June 9

Orthopedics

Speaker

Gerald Weniger, MPAS, MEd, ATC, PA-C

View Gerald’s Bio

6:30 – 8:00 am

Registration and Breakfast

7:30 – 8:30 am

Not Just Child’s Play: A Review of Pediatric Orthopedics

Most clinicians are familiar with common pediatric injuries. But are you still confused by the Salter-Harris classification? Do you remember the differences between a slipped capital femoral epiphysis and Legg-Calve-Perthes disease? This presentation will review these pediatric musculoskeletal conditions as well as osteochondritis dissecans, apophysitis, various fracture patterns, and more.

8:30 – 9:30 am

Don’t Shoulder the Burden: Demystifying Physical Exam of the Shoulder

Many clinicians are comfortable with the evaluation of musculoskeletal conditions of the hand, wrist, foot, or ankle. But for some reason, evaluation of shoulder pain is often more daunting. SLAP tears? Hawkins-Kennedy Test? Bankart tears? O’Brien’s Test? This presentation will help you make sense of all the orthopedic acronyms and eponyms so that you can more confidently evaluate a patient with shoulder pain. Useful special tests will be explained and demonstrated.

9:30 – 9:45 am

Break

9:45 – 11:15 am

We’ll Give You a Hand: Wrist & Hand Pathologies You May Be Missing

Most clinicians are familiar with the evaluation and treatment of common hand and wrist conditions like carpal tunnel syndrome, wrist sprains, and trigger finger. But what about more obscure pathologies? This presentation will review less common musculoskeletal conditions of the hand and wrist such as Keinbock’s disease, mallet finger, Jersey finger, skier’s thumb, scaphoid fractures, and more.

11:15 am – 12:30 pm

Sponsored Lunch or Lunch on Your Own

12:30 – 2:00 pm

Keys to the Knee: Simplifying Evaluation of the Knee

Evaluation of the knee has changed and evolved over the years. Do you perform a Lachman’s test or anterior drawer? Is McMurray’s test still clinically useful? What is a Thessaly test? This presentation will discuss these special tests and more; while making sense of a musculoskeletal exam of the knee. Special attention will be directed towards acute and degenerative meniscus tears, and when referral to orthopedics is prudent.

2:00 – 2:15 pm

Break

2:15 – 3:45 pm

Get a Leg Up on Musculoskeletal Pharmacology (Rx 0.5)

Are you running out of options for treating joint and muscle pain? Have NSAIDS and acetaminophen stopped working? Ready to lessen your use of opioids? This presentation will review alternative medications for MSK pain. It will also provide an introduction to joint injections such as hyaluronic acid injections, platelet-rich plasma therapy, and other emerging procedures.

Day Four – Friday, June 10

Women’s Health

Speaker

Mimi Secor, DNP, FNP-BC, FAANP, FAAN

View Mimi’s Bio

6:30 – 8:00 am

Registration and Breakfast

7:30 – 8:30 am

Women’s Health Guidelines Update (Rx 0.25)

During this session, the epidemiology of selected conditions (breast cancer, STIs, cervical cancer, contraception, osteoporosis) will be discussed. New guidelines will be described focusing on the changes and rationale for these changes. Controversies among various guidelines will be presented and the clinical implications of these differences will be explored.

8:30 – 9:30 am

Contraceptive Update: What’s New? (Rx 1.0)

During this session, trends and contraceptive challenges facing clinicians and patients will be discussed. The new CDC medical eligibility criteria for prescribing various contraceptive methods and medical conditions will be explained. New contraceptive research regarding efficacy, risks, benefits as this pertains to prescribing will also be presented.

9:30 – 9:45 am

Break

9:45 – 11:15 am

STI Update: Focus on the Female (Rx 0.25)

During this session the epidemiology of STIs will be discussed including recent trends and statistics. Explain diagnostic work-up for selected STIs including changes in HIV testing. Management will focus on recent changes including new gonorrhea treatment. This session will focus on the female and certain selected conditions including Herpes, CT/GC, PID, Cervicitis, HIV and Sexual Assault.

11:15 am – 12:30 pm

Sponsored Lunch or Lunch on Your Own

12:30 – 2:00 pm

PCOS: Common, Complex and Serious (Rx 0.25)

During this session the epidemiology, complex pathophysiology, and serious associated risks and complications will be discussed. Symptoms, signs and diagnostic workup will be described. Discuss “best practice” management approaches including pharmacologic treatments and lifestyle approaches.

2:00 – 2:15 pm

Break

2:15 – 3:45 pm

Menopause Alert: Hot Flashes, Vaginal Atrophy, Libido and More (Rx 0.75)

Describe epidemiology/physiology of menopause, Metabolic changes/Risks, Vasomotor Symptoms (VMS), Vulvovaginal Atrophy (VVA) and Low Libido (HSDD*). Discuss the diagnosis of VMS and Vulvovaginal Atrophy. Explain pharm/non pharm options/alternatives for treatment of VMS, VVA, and Low Libido/HSDD (*hypoactive sexual desire disorder).